The contributions of cardiac myosin binding protein C and troponin I phosphorylation to β-adrenergic enhancement of in vivo cardiac function

Journal of Physiology

Volumn 594, Issue 3, 2016, Pages 669-686

  Gresham, Kenneth S ^a   Stelzer, Julian E ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOBUTAMINE; MYOSIN BINDING PROTEIN C; SERINE; TROPONIN I; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; CARRIER PROTEIN; MYOSIN-BINDING PROTEIN C;

ADRENERGIC ACTIVITY; ADRENERGIC STIMULATION; ADULT; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIASTOLE; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE RELAXATION; HEART VENTRICLE HYPERTROPHY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; TELEMETRY; TRANSGENIC MOUSE; ANIMAL; BLOOD PRESSURE; CARDIAC MUSCLE; CARDIOMEGALY; GENETICS; HEART; METABOLISM; MUSCLE FIBRIL; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ADRENERGIC BETA-1 RECEPTOR AGONISTS; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; CARRIER PROTEINS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOBUTAMINE; FEMALE; HEART; MALE; MICE, TRANSGENIC; MYOCARDIUM; MYOFIBRILS; PHOSPHORYLATION; RECEPTORS, ADRENERGIC, BETA; TROPONIN I;

EID: 84956673393     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/JP270959     Document Type: Article

References (50)

1. Adler D, Monrad ES, Hess OM, Krayenbuehl HP & Sonnenblick EH (1996a). Time to dP/dt(max), a useful index for evaluation of contractility in the catheterization laboratory. Clin Cardiol 19, 397-403.
2. Adler D, Nikolic SD, Sonnenblick EH & Yellin EL (1996b). Time to dP/dtmax, a preload-independent index of contractility: open-chest dog study. Basic Res Cardiol 91, 94-100.
3. Bers DM (2008). Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol 70, 23-49.
4. Biesiadecki BJ, Davis JP, Ziolo MT & Janssen PML (2014). Tri-modal regulation of cardiac muscle relaxation; intracellular calcium decline, thin filament deactivation, and cross-bridge cycling kinetics. Biophys Rev 6, 273-289.
5. Bilchick KC, Duncan JG, Ravi R, Takimoto E, Champion HC, Gao WD, Stull LB, Kass DA & Murphy AM (2007). Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function. Am J Physiol Heart Circ Physiol 292, H318-H325.
6. Campbell K (1997). Rate constant of muscle force redevelopment reflects cooperative activation as well as cross-bridge kinetics. Biophys J 72, 254-262.
7. Cheng Y, Wan X, McElfresh TA, Chen X, Gresham KS, Rosenbaum DS, Chandler MP & Stelzer JE (2013). Impaired contractile function due to decreased cardiac myosin binding protein C content in the sarcomere. Am J Physiol Heart Circ Physiol 305, H52-H65.
8. Colson BA, Patel JR, Chen PP, Bekyarova T, Abdalla MI, Tong CW, Fitzsimons DP, Irving TC & Moss RL (2012). Myosin binding protein-C phosphorylation is the principal mediator of protein kinase A effects on thick filament structure in myocardium. J Mol Cell Cardiol 53, 609-616.
9. Davis JP, Norman C, Kobayashi T, Solaro RJ, Swartz DR & Tikunova SB (2007). Effects of thin and thick filament proteins on calcium binding and exchange with cardiac troponin C. Biophys J 92, 3195-3206.
10. Decker RS, Decker ML, Kulikovskaya I, Nakamura S, Lee DC, Harris K, Klocke FJ & Winegrad S (2005). Myosin-binding protein C phosphorylation, myofibril structure, and contractile function during low-flow ischemia. Circulation 111, 906-912.
11. Decker RS, Nakamura S, Decker ML, Sausamuta M, Sinno S, Harris K, Klocke FJ, Kulikovskaya I & Winegrad S (2012). The dynamic role of cardiac myosin binding protein-C during ischemia. J Mol Cell Cardiol 52, 1145-1154.
12. El-Armouche A, Pohlmann L, Schlossarek S, Starbatty J, Yeh Y-H, Nattel S, Dobrev D, Eschenhagen T & Carrier L (2007). Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J Mol Cell Cardiol 43, 223-229.
13. Fearnley CJ, Roderick HL & Bootman MD (2011). Calcium signaling in cardiac myocytes. Cold Spring Harb Perspect Biol 3, a004242.
14. Fentzke RC, Buck SH, Patel JR, Lin H, Wolska BM, Stojanovic MO, Martin AF, Solaro RJ, Moss RL & Leiden JM (1999). Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J Physiol 517, 143-157.
15. Fukuda N, Wu Y, Nair P & Granzier HL (2005). Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform-dependent manner. J Gen Physiol 125, 257-271.
16. Fu Q, Chen X & Xiang YK (2013). Compartmentalization of β-adrenergic signals in cardiomyocytes. Trends Cardiovasc Med 23, 250-256.
17. Gresham KS, Mamidi R & Stelzer JE (2014). The contribution of cardiac myosin binding protein-c Ser282 phosphorylation to the rate of force generation and in vivo cardiac contractility. J Physiol 592, 3747-3765.
18. Gruen M, Prinz H & Gautel M (1999). cAPK-phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin-S2 in an on-off fashion. FEBS Lett 453, 254-259.
19. Hamdani N, de Waard M, Messer AE, Boontje NM, Kooij V, van Dijk S, Versteilen A, Lamberts R, Merkus D, Dos Remedios C, Duncker DJ, Borbely A, Papp Z, Paulus W, Stienen GJM, Marston SB & van der Velden J (2008). Myofilament dysfunction in cardiac disease from mice to men. J Muscle Res Cell Motil 29, 189-201.
20. Hanft LM, Korte FS & McDonald KS (2008). Cardiac function and modulation of sarcomeric function by length. Cardiovasc Res 77, 627-636.
21. Han YS, Arroyo J & Ogut O (2013). Human heart failure is accompanied by altered protein kinase A subunit expression and post-translational state. Arch Biochem Biophys 538, 25-33.
22. Herron TJ, Korte FS & McDonald KS (2001). Power output is increased after phosphorylation of myofibrillar proteins in rat skinned cardiac myocytes. Circ Res 89, 1184-1190.
23. Hinken AC & Solaro RJ (2007). A dominant role of cardiac molecular motors in the intrinsic regulation of ventricular ejection and relaxation. Physiol Bethesda Md 22, 73-80.
24. Jacques AM, Copeland O, Messer AE, Gallon CE, King K, McKenna WJ, Tsang VT & Marston SB (2008). Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle. J Mol Cell Cardiol 45, 209-216.
25. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, Kahaleh MB, Xie Z, Malhotra D, Kolodkin NI, Lakatta EG, Fedorova OV, Bagrov AY & Shapiro JI (2006). Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 47, 488-495.
26. 2+-sensitivity in human myocardium depends on the phosphorylation background. J Mol Cell Cardiol 48, 954-963.
27. Layland J, Grieve DJ, Cave AC, Sparks E, Solaro RJ & Shah AM (2004). Essential role of troponin I in the positive inotropic response to isoprenaline in mouse hearts contracting auxotonically. J Physiol 556, 835-847.
28. Lorell BH & Carabello BA (2000). Left ventricular hypertrophy pathogenesis, detection, and prognosis. Circulation 102, 470-479.
29. Mamidi R, Gresham KS & Stelzer JE (2014). Length-dependent changes in contractile dynamics are blunted due to cardiac myosin binding protein-C ablation. Front Physiol 5, 461.
30. Matsubara H, Takaki M, Yasuhara S, Araki J & Suga H (1995). Logistic time constant of isovolumic relaxation pressure - time curve in the canine left ventricle better alternative to exponential time constant. Circulation 92, 2318-2326.
31. McDonald KS, Hanft LM, Domeier TL & Emter CA (2012). Length and PKA dependence of force generation and loaded shortening in porcine cardiac myocytes. Biochem Res Int 2012, 371415.
32. Messer AE, Jacques AM & Marston SB (2007). Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J Mol Cell Cardiol 42, 247-259.
33. Metzger JM (1995). Myosin binding-induced cooperative activation of the thin filament in cardiac myocytes and skeletal muscle fibers. Biophys J 68, 1430-1442.
34. Moss RL & Fitzsimons DP (2010). Regulation of contraction in mammalian striated muscles - the plot thickens. J Gen Physiol 136, 21-27.
35. Nagayama T, Takimoto E, Sadayappan S, Mudd JO, Seidman JG, Robbins J & Kass DA (2007). Control of in vivo left ventricular contraction/relaxation kinetics by myosin binding protein C: protein kinase A phosphorylation dependent and independent regulation. Circulation 116, 2399-2408.
36. 2+ sensitivity and ATPase activity in the mouse myocardium. J Physiol 552, 845-857.
37. Post SR, Hammond HK & Insel PA (1999). β-Adrenergic receptors and receptor signaling in heart failure. Annu Rev Pharmacol Toxicol 39, 343-360.
38. Rosas PC, Liu Y, Abdalla MI, Thomas CM, Kidwell DT, Dusio GF, Mukhopadhyay D, Kumar R, Baker KM, Mitchell BM, Powers PA, Fitzsimons DP, Patel BG, Warren CM, Solaro RJ, Moss RL & Tong CW (2015). Phosphorylation of cardiac myosin binding protein-C is a critical mediator of diastolic function. Circ Heart Fail 8, 582-594.
39. Sadayappan S, Gulick J, Osinska H, Martin LA, Hahn HS, Dorn GW, Klevitsky R, Seidman CE, Seidman JG & Robbins J (2005). Cardiac myosin-binding protein-C phosphorylation and cardiac function. Circ Res 97, 1156-1163.
40. Sakthivel S, Finley NL, Rosevear PR, Lorenz JN, Gulick J, Kim S, VanBuren P, Martin LA & Robbins J (2005). In vivo and in vitro analysis of cardiac troponin I phosphorylation. J Biol Chem 280, 703-714.
41. Solaro RJ (2010). Sarcomere control mechanisms and the dynamics of the cardiac cycle. J Biomed Biotechnol 2010, 105648.
42. Stehle R & Iorga B (2010). Kinetics of cardiac sarcomeric processes and rate-limiting steps in contraction and relaxation. J Mol Cell Cardiol 48, 843-850.
43. Stelzer JE, Patel JR & Moss RL (2006). Protein kinase A-mediated acceleration of the stretch activation response in murine skinned myocardium is eliminated by ablation of cMyBP-C. Circ Res 99, 884-890.
44. Stelzer JE, Patel JR, Walker JW & Moss RL (2007). Differential roles of cardiac myosin-binding protein C and cardiac troponin I in the myofibrillar force responses to protein kinase A phosphorylation. Circ Res 101, 503-511.
45. Takimoto E, Soergel DG, Janssen PML, Stull LB, Kass DA & Murphy AM (2004). Frequency- and afterload-dependent cardiac modulation in vivo by troponin i with constitutively active protein kinase A phosphorylation sites. Circ Res 94, 496-504.
46. Tong CW, Stelzer JE, Greaser ML, Powers PA & Moss RL (2008). Acceleration of crossbridge kinetics by protein kinase A phosphorylation of cardiac myosin binding protein C modulates cardiac function. Circ Res 103, 974-982.
47. Tong CW, Wu X, Liu Y, Rosas PC, Sadayappan S, Hudmon A, Muthuchamy M, Powers PA, Valdivia HH & Moss RL (2015). Phosphoregulation of cardiac inotropy via myosin binding protein-C during increased pacing frequency or β1-adrenergic stimulation. Circ Heart Fail 8, 595-604.
48. Van der Velden J (2011). Diastolic myofilament dysfunction in the failing human heart. Pflügers Arch 462, 155-163.
49. Wilson K & Lucchesi PA (2014). Myofilament dysfunction as an emerging mechanism of volume overload heart failure. Pflügers Arch Eur J Physiol 466, 1065-1077.
50. Zakhary DR, Moravec CS, Stewart RW & Bond M (1999). Protein kinase A (PKA)-dependent troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy. Circulation 99, 505-510.